raloxifene has been researched along with pd 0325901 in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Beerli, R; Blanz, J; Drückes, P; Fendrich, G; Gassmann, E; Glatthar, R; Gutmann, S; Hornfeld, J; Martiny-Baron, G; Mattes, H; Möbitz, H; Peel, JE; Sparrer, H; Spence, F; Stojanovic, A; Troxler, T | 1 |
1 other study(ies) available for raloxifene and pd 0325901
Article | Year |
---|---|
Discovery of Imidazoquinolines as a Novel Class of Potent, Selective, and in Vivo Efficacious Cancer Osaka Thyroid (COT) Kinase Inhibitors.
Topics: Animals; Crystallography, X-Ray; Dogs; Dose-Response Relationship, Drug; Drug Discovery; Humans; Imidazoles; Male; MAP Kinase Kinase Kinases; Models, Molecular; Molecular Structure; Protein Kinase Inhibitors; Proto-Oncogene Proteins; Quinolines; Rats; Rats, Sprague-Dawley; Structure-Activity Relationship; Tumor Necrosis Factor-alpha | 2016 |